Yuanyuan Cheng
Theranostics (New Zealand)(NZ)Tianjin Medical University(CN)
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, HER2/EGFR in Cancer Research, Photodynamic Therapy Research Studies, Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation
Most-Cited Works
- → An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling(2020)163 cited
- → Nucleus-targeting near-infrared nanoparticles based on TAT peptide-conjugated IR780 for photo-chemotherapy of breast cancer(2019)126 cited
- → RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo(2009)70 cited
- → Self-assembly of pentapeptides into morphology-adaptable nanomedicines for enhanced combinatorial chemo-photodynamic therapy(2020)68 cited
- → CD44/Cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients(2013)61 cited
- → Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer(2021)50 cited
- → ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc(2021)46 cited
- → Silencing of Long Noncoding RNA LINC00324 Interacts with MicroRNA-3200-5p to Attenuate the Tumorigenesis of Gastric Cancer via Regulating BCAT1(2020)20 cited
- → Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States(2023)18 cited
- → Versatile Red Blood Cells for Triple‐Negative Breast Cancer Treatment via Stepwise Photoactivations(2022)17 cited